ATE466935T1 - Verfahren zur entfernung eines nichtmetallischen proteinhemmers aus einer flüssigen pharmazeutischen zubereitung - Google Patents

Verfahren zur entfernung eines nichtmetallischen proteinhemmers aus einer flüssigen pharmazeutischen zubereitung

Info

Publication number
ATE466935T1
ATE466935T1 AT07726469T AT07726469T ATE466935T1 AT E466935 T1 ATE466935 T1 AT E466935T1 AT 07726469 T AT07726469 T AT 07726469T AT 07726469 T AT07726469 T AT 07726469T AT E466935 T1 ATE466935 T1 AT E466935T1
Authority
AT
Austria
Prior art keywords
pharmaceutical preparation
liquid pharmaceutical
inhibitor
removal
protein inhibitor
Prior art date
Application number
AT07726469T
Other languages
English (en)
Inventor
Michael Jensen
Ulrik Nysted
Karen Pilgaard
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Application granted granted Critical
Publication of ATE466935T1 publication Critical patent/ATE466935T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6408Serine endopeptidases (3.4.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • General Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT07726469T 2006-02-24 2007-02-22 Verfahren zur entfernung eines nichtmetallischen proteinhemmers aus einer flüssigen pharmazeutischen zubereitung ATE466935T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06110412 2006-02-24
PCT/EP2007/051711 WO2007096406A1 (en) 2006-02-24 2007-02-22 A method of removing a non-metallic protein inhibitor from a liquid pharmaceutical preparation

Publications (1)

Publication Number Publication Date
ATE466935T1 true ATE466935T1 (de) 2010-05-15

Family

ID=36595910

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07726469T ATE466935T1 (de) 2006-02-24 2007-02-22 Verfahren zur entfernung eines nichtmetallischen proteinhemmers aus einer flüssigen pharmazeutischen zubereitung

Country Status (6)

Country Link
US (1) US20090111751A1 (de)
EP (1) EP1989304B1 (de)
JP (1) JP2009527536A (de)
AT (1) ATE466935T1 (de)
DE (1) DE602007006282D1 (de)
WO (1) WO2007096406A1 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3751605D1 (de) * 1986-01-06 1996-01-04 Blood Systems Inc Therapeutisches Blutprodukt, Mittel und Verfahren zu dessen Erzeugung.
US5288612A (en) * 1991-07-03 1994-02-22 The Scripps Research Institute Assay methods for detecting serum proteases, particularly activated protein C
SE505274C2 (sv) * 1995-10-24 1997-07-28 Sten Andersson Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning

Also Published As

Publication number Publication date
EP1989304A1 (de) 2008-11-12
WO2007096406A1 (en) 2007-08-30
JP2009527536A (ja) 2009-07-30
US20090111751A1 (en) 2009-04-30
EP1989304B1 (de) 2010-05-05
DE602007006282D1 (de) 2010-06-17

Similar Documents

Publication Publication Date Title
NZ597756A (en) Method for purifying recombinant adamts13 and other proteins and compositions thereof
WO2007008071A3 (en) Method for detecting peptides comprising a cross-beta structure
DK2126586T3 (da) Direkte bestemmelse af vitamin D i serum eller plasma
ATE506861T1 (de) Molkenproteinträger zur abgabe von aktivsubstanzen
DE602005009856D1 (de) Verfahren zur reinigung von fsh
EA201200861A1 (ru) Антагонисты pcsk9
NZ571352A (en) Separation of nucleic acids from a liquid sample using a liquid flow device
EA200501903A1 (ru) Удаление кислородсодержащего вещества из потока олефинов
CL2014001100A1 (es) Formulacion enzimatica liquida que comprende por lo menos una enzima para el entrecruzamiento y/o modificacion de proteinas lacteas en suspension de poliol-agua que contiene desde 25 a 100% (p/p) de poliol y que tiene un valor de ph dentro de la escala de 4,4 a 5,1; y metodo para preparar la formulacion.
WO2012059643A3 (en) Method for fractionating of lignocellulosic material and novel ionic liquids therefor
DE602008004747D1 (de) Verfahren zur aufreinigung hydrophober proteine
WO2007130535A3 (en) Novel protein fusion/tag technology
WO2008081094A3 (fr) Methode de mesure fonctionnelle de l'activite de la thrombomoduline plasmatique
DE602007003378D1 (de) Entfernung permanganatreduzierender verunreinigungen aus essigsäure
WO2006053251A3 (en) Method of measuring amyloid-beta peptides
NZ596671A (en) Assays for influenza virus hemagglutinins
ATE440980T1 (de) Verfahren zur hydrolyse von polyphosphorsäure in geformten artikeln
DE502005003227D1 (de) Verfahren zur isolierung von alpha-mangostin
WO2006135938A3 (en) Fluorometric method for monitoring a clean-in-place system
EA200701072A1 (ru) Препараты бензотиазола и их применение
DE502007004242D1 (de) DNS-Konstrukt und Verfahren zur fermentativen Herstellung von Fusionsproteinen
ATE462714T1 (de) Verfahren zur extraktion eines intrazellulären proteins aus einer fermentationsbrühe
EA200801284A1 (ru) Способ очистки и удаления эндотоксина
ATE526302T1 (de) Verfahren zur aufreinigung von hexafluorpropendimeren
ATE466935T1 (de) Verfahren zur entfernung eines nichtmetallischen proteinhemmers aus einer flüssigen pharmazeutischen zubereitung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties